Genetic Counseling and Diagnostic Guidelines for Couples with Infertility And/Or Recurrent Miscarriage

Total Page:16

File Type:pdf, Size:1020Kb

Genetic Counseling and Diagnostic Guidelines for Couples with Infertility And/Or Recurrent Miscarriage medizinische genetik 2021; 33(1): 3–12 Margot J. Wyrwoll, Sabine Rudnik-Schöneborn, and Frank Tüttelmann* Genetic counseling and diagnostic guidelines for couples with infertility and/or recurrent miscarriage https://doi.org/10.1515/medgen-2021-2051 to both partners prior to undergoing assisted reproduc- Received January 16, 2021; accepted February 11, 2021 tive technology. In couples with recurrent miscarriages, Abstract: Around 10–15 % of all couples are infertile, karyotyping is recommended to detect balanced structural rendering infertility a widespread disease. Male and fe- chromosomal aberrations. male causes contribute equally to infertility, and, de- Keywords: female infertility, male infertility, miscarriages, pending on the defnition, roughly 1 % to 5 % of all genetic counseling, ART couples experience recurrent miscarriages. In German- speaking countries, recommendations for infertile cou- ples and couples with recurrent miscarriages are pub- lished as consensus-based (S2k) Guidelines by the “Ar- Introduction beitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften” (AWMF). This article summarizes the A large proportion of genetic consultation appointments current recommendations with regard to genetic counsel- is attributed to infertile couples and couples with recur- ing and diagnostics. rent miscarriages. Infertility, which is defned by the WHO Prior to genetic counseling, the infertile couple as the inability to achieve a pregnancy after one year of must undergo a gynecological/andrological examination, unprotected intercourse [1], afects 10–15 % of all couples, which includes anamnesis, hormonal profling, physical thus rendering infertility a widespread disease, compara- examination and genital ultrasound. Women should be ex- ble to, e. g., high blood pressure or depression. Histori- amined for the presence of hyperandrogenemia. Men must cally, the female partner has been the focus of diagnos- further undergo a semen analysis. Based on the overall re- tics and counseling, but the causes of infertility are well sults, hyper- or hypogonadotropic hypogonadism can be known to be equally distributed between the male and fe- diagnosed in both sexes. male partners. In fact, in one-third of all infertility cases, Female genetic diagnostics for infertility comprise both partners contribute to the pathogenesis [2]. Since karyotyping, analysis of the FMR1 premutation and a gene 5–10 % of female infertility cases and 5–20 % of male in- panel including genes associated with congenital hypo- fertility cases have identifable genetic roots in currently gonadotropic hypogonadism (CHH) or congenital adrenal established diagnostic analyses [3, 4], such diagnostics hyperplasia. Male genetic diagnostics for infertility com- and respective counseling should account for both part- prise karyotyping, screening for AZF microdeletions, CFTR ners equally. Due to novel technologies such as next gen- analysis and a gene panel including genes associated eration sequencing (NGS) and an increasing number of with CHH. Also, gene panels are increasingly being used known monogenic causes of both male and female infer- to causally clarify specifc phenotypes such as defective tility, more diagnostics increase the complexity of genetic sperm morphology/motility or azoospermia. As infertile counseling and informed consent for those couples. couples have an increased risk for chromosomal aber- In contrast to couples who present with infertility, cou- rations, a chromosomal analysis should also be ofered ples with recurrent miscarriages regularly do not have any difculty achieving a pregnancy but fail to maintain it. *Corresponding author: Frank Tüttelmann, Institute of Reproductive Genetics, University of Münster, Vesaliusweg 12-14, 48149 Münster, Overall, miscarriages occur frequently, as 5 % of all cou- Germany, e-mail: [email protected] ples of reproductive age experience recurrent (at least two) Margot J. Wyrwoll, Institute of Reproductive Genetics, University of miscarriages [5]. The percentage of couples meeting the Münster, Vesaliusweg 12-14, 48149 Münster, Germany, e-mail: WHO defnition of recurrent miscarriage (three or more [email protected] miscarriages before 20 weeks gestation) is estimated to Sabine Rudnik-Schöneborn, Institute of Human Genetics, Medical University Innsbruck, 6020 Innsbruck, Austria, e-mail: be 1 % [3]. Most miscarriages take place within the frst [email protected] trimester and are the result of numerical chromosomal Open Access. © 2021 Wyrwoll et al., published by De Gruyter. This work is licensed under the Creative Commons Attribution 4.0 International License. 4 | M. J. Wyrwoll et al., Review genetics infertility & miscarriage aberrations. In most cases, the fetus is not further exam- Female hyper- and hypogonadotropic ined, leaving the specifc cause undetermined. hypogonadism Although both infertility and miscarriages are com- mon, these issues remain socially taboo. Therefore, con- For genetic testing it is important to distinguish hyper- and cerned couples often feel exclusively afected by this prob- hypogonadotropic hypogonadism. Hypergonadotropic lem and avoid discussing the topic with their peers, which hypogonadism is characterized by elevated gonadotropins puts these couples under additional pressure; therefore, (FSH/LH) in the presence of normal or reduced estrogen genetic counseling of infertile couples or couples with mis- levels and point toward a primary ovarian dysfunction. carriages also requires an associated educational compo- Hypogonadotropic or hypothalamic hypogonadism (re- nent. On top of that, afected couples often sufer enor- duced FSH/LH and reduced estrogen levels) is very rare in mous psychological stress. Furthermore, the age of the females and is mostly caused by a reduced secretion of the female partner constitutes a critical factor for conceiv- gonadotropin releasing hormones (GnRH). Genetic causes ing a child naturally. Notably, the average age of women are complex and include congenital hypogonadotropic receiving treatments at fertility centers in Europe is 35 hypogonadism (CHH) and metabolic dysfunctions of the years [6], resulting in lower pregnancy and higher miscar- pituitary gland. riage rates when compared with the normal fertile popula- tion. This review provides an overview of important genetic Hyperandrogenemia conditions and the recommended diagnostic algorithms for couples with recurrent miscarriages or infertile cou- Important diferential diagnoses of hyperandrogenemia ples requesting assisted reproductive technology (ART). are polycystic ovary syndrome (PCOS) and congenital The corresponding recommendations were published in adrenal hyperplasia (CAH). Women with PCOS present German-speaking countries as S2k Guidelines by the “Ar- with cycle abnormalities and clinical signs of hyperandro- beitsgemeinschaft der Wissenschaftlichen Medizinischen genemia. Following the Rotterdam criteria, the diagnosis Fachgesellschaften” (AWMF) [4, 7]. For a more in-depth of PCOS can be established if testosterone levels are in- overview, both guidelines have been summarized in arti- creased and SHBG levels are reduced, along with specifc cles concerning the female [8–10] and male [10, 11] con- ultrasound changes of the ovaries (more than 12 antral fol- siderations. licles of less than 10 mm in diameter in each ovary). More than 50 % of patients show an insulin resistance, which can best be detected with the HOMA index. If hyperandrogenemia is associated with high 17-OHP Gynecological examinations for and DHEAS, this points toward an adrenal androgen pro- reduced fertility duction as seen in CAH. Classical CAH, most often caused by severe biallelic mutations of the CYP21A2 gene, is nowa- Diagnostic algorithms generally start with determining days generally detected by newborn screening for early the patient’s personal disease history including pedigree treatment. Non-classical or late-onset CAH presents like information (anamnesis) followed by clinical and labo- PCOS, with cycle abnormalities, subfertility and hyperan- ratory examinations. Anamnesis and physical examina- drogenemia. The most frequent 21-hydroxylase defciency tions should address pubertal development, signs of hypo- is suspected in the case of elevated 17-OHP and relative re- gonadism or cortisol excess. Anomalies of the inner geni- duction of cortisol. Final diagnosis is generally established tal tract can be sufciently detected by a vaginal sono- by molecular genetic analysis. graphy. The endocrine basics include measuring LH, FSH, TSH, prolactin, testosterone, DHEAS, SHBG, free andro- Anti-Müllerian hormone gen index, estradiol and Anti-Müllerian hormone (AMH). If there are anovulatory cycles, a single progesterone mea- AMH is synthesized by primordial follicles and plays a surement should be obtained at about day 21 in an as- role in determining ovarian activity. The activity of AMH is sumed cycle. If there are abnormal fndings in the en- inversely correlated with age and shows considerable in- docrine basics, further diagnostic steps proceed, e. g., terindividual diferences. Reduced AMH levels are of poor 17-OH progesterone (17-OHP) measurements in the pres- predictive value regarding fertility but are used to estimate ence of hyperandrogenemia. the ovarian reserve in the context of ART. Besides genetic M. J. Wyrwoll et al., Review genetics infertility & miscarriage | 5 factors leading to primary or premature ovarian insuf- mic men with increased FSH levels and reduced
Recommended publications
  • Non-Syndromic Monogenic Male Infertility
    Acta Biomed 2019; Vol. 90, Supplement 10: 62-67 DOI: 10.23750/abm.v90i10-S.8762 © Mattioli 1885 Review Non-syndromic monogenic male infertility Giulia Guerri1, Tiziana Maniscalchi2, Shila Barati2, Gian Maria Busetto3, Francesco Del Giudice3, Ettore De Berardinis3, Rossella Cannarella4, Aldo Eugenio Calogero4, Matteo Bertelli2 1 MAGI’s Lab, Rovereto (TN), Italy; 2 MAGI Euregio, Bolzano, Italy; 3 Department of Urology, University of Rome La Sapien- za, Policlinico Umberto I, Rome, Italy; 4 Department of Clinical and Experimental Medicine, University of Catania, Catania, Italy Summary. Infertility is a widespread clinical problem affecting 8-12% of couples worldwide. Of these, about 30% are diagnosed with idiopathic infertility since no causative factor is found. Overall 40-50% of cases are due to male reproductive defects. Numerical or structural chromosome abnormalities have long been associ- ated with male infertility. Monogenic mutations have only recently been addressed in the pathogenesis of this condition. Mutations of specific genes involved in meiosis, mitosis or spermiohistogenesis result in spermato- genic failure, leading to the following anomalies: insufficient (oligozoospermia) or no (azoospermia) sperm production, limited progressive and/or total sperm motility (asthenozoospermia), altered sperm morphology (teratozoospermia), or combinations thereof. Androgen insensitivity, causing hormonal and sexual impair- ment in males with normal karyotype, also affects male fertility. The genetic causes of non-syndromic mono- genic of male infertility are summarized in this article and a gene panel is proposed. (www.actabiomedica.it) Key words: male infertility, oligozoospermia, azoospermia, asthenozoospermia, teratozoospermia, spermato- genic failure, androgen insensitivity syndrome Introduction development. Genetic causes of male infertility are outlined in Table 1.
    [Show full text]
  • Female Fertility Assessment
    Assessment Female Fertility Assessment Fertility challenges impact millions of couples in the United States and Medical conditions that impact the function of a woman’s ovaries, fallopian around the globe. Approximately 10% of US women ages 15-44 have tubes, or uterus can contribute to female infertility. Anovulation causes can difficulty getting or staying pregnant.1 Infertility is defined as the inability to include underweight, overweight/obesity, PCOS, endometriosis, diminished get pregnant after one year of trying (or six months in a woman 35 years or ovarian reserve (e.g., due to age), functional hypothalamic amenorrhea older) through unprotected sex.2 In addition to age and coital frequency,3 (FHA), dysfunction of the hypothalamus or pituitary gland, premature hormonal health has a major physiological influence on fertility. ovarian insufficiency, and menopause.2,13 In women, ovulation depends on a regular menstrual cycle, a 28-day Reproductive endocrinologists specialize in infertility and also support symphony of the hypothalamic-pituitary-gonadal (HPG) axis involving women who have experienced recurrent pregnancy loss; however, a specific fluctuations in estrogen and progesterone levels, shown in the multidisciplinary clinical team approach addressing hormonal, lifestyle, Figures in this assessment.4,5 The pituitary gland sends pulses of follicle- social support, and other factors is ideal. While this clinical tool focuses stimulating hormone (FSH) in the follicular phase (days 1-14), triggering on female fertility, it is important to point out that approximately 40% the rise of estrogen, which stimulates the hypothalamic release of of fertility cases involve a male factor (e.g., low sperm count or quality).3 gonadotropin-releasing hormone (GnRH), causing the pituitary secretion Thus, a couple’s approach to fertility assessment is prudent to uncover and of luteinizing hormone (LH).4,5 FSH and LH surges result in egg release from address underlying root causes preventing conception.
    [Show full text]
  • Prevalence Along with Diagnostic Modalities and Treatment of Female Infertility Due to Female Genital Disorders
    Virology & Immunology Journal MEDWIN PUBLISHERS ISSN: 2577-4379 Committed to Create Value for Researchers Prevalence Along with Diagnostic Modalities and Treatment of Female Infertility Due to Female Genital Disorders Omer Iqbal1 and Faiza Naeem2* Research Article 1College of Medicine and Pharmacy, Ocean University of China Qingdao, Shandong province, Volume 4 Issue 3 China Received Date: August 16, 2020 2Institute of Pharmacy, Lahore College for Women University, Pakistan Published Date: September 08, 2020 DOI: 10.23880/vij-16000249 *Corresponding author: Faiza Naeem, Institute of Pharmacy, Lahore College for Women University, Lahore, Pakistan, Email: [email protected] Abstract Infertility is a communal pathological ailment now-a-days worldwide and approximately females are mostly suffering from this condition. In previous studies, out of 2.4 million married couples have females in between the ages from 15-44 year; 1.0 million couples were suffering from primary infertility and 1.4 million couples had secondary infertility. The infertility causes are ovulatory factors, dietary factors, psychological factors, abnormal endocrine functions, fallopian tube disorders etc. PCOS, PIDs, endometriosis. The ultrasonography is the most powerful tool for diagnosis. The treatment involves medical, surgical and assisted reproduction. Medical treatment includes clomiphene, metformin, iron & folic acid supplements along with oral- contraceptives. Surgical treatment is operative laparoscopy and assisted reproduction is achieved by IVF, GIFT & IUI etc. It is concluded from the study that the percentage prevalence of female infertility among ages was higher in age group (25-34) years (76%) and it was mostly secondary infertility (54%). The main pathological factor of female infertility in Sialkot city was PCOS, which was 52% of evaluated patients.
    [Show full text]
  • Genetics of Male Infertility: Genes Implicated in Non-Obstructive
    Genetics of male infertility : genes implicated in non-obstructive azoospermia and severe oligozoospermia Özlem Okutman To cite this version: Özlem Okutman. Genetics of male infertility : genes implicated in non-obstructive azoospermia and severe oligozoospermia. Reproductive Biology. Université de Strasbourg, 2015. English. NNT : 2015STRAJ049. tel-01372898 HAL Id: tel-01372898 https://tel.archives-ouvertes.fr/tel-01372898 Submitted on 27 Sep 2016 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. THESIS P`VsVJ VR G77 Ö<CVI OKTMAN DV`VJRVR Q``1H1:CC7 SV] VIGV` . IJ P:` 1:C F%C`1CCIVJ Q` .V RV_%1`VIVJ s `Q` .V DV$`VV Q` DQH Q` Q` P.1CQsQ].7 1J SH1VJHVs ``QI .V J10V`s1 7 Q` S `:sGQ%`$ D1sH1]C1JV7 L1`V SH1VJHV :JR HV:C . S]VH1:C1 77 CVCC%C:` B1QCQ$7 :JR DV0VCQ]IVJ GVJV 1Hs Q` I:CV 1J`V` 1C1 7 GVJVs 1I]C1H: VR 1J JQJRQGs `%H 10V :<QQs]V`I1: :JR sV0V`V QC1$Q<QQs]V`I1: T.Vs1s R1`VH Q`7 P`8 S X].:JV IILLE J10V`s1 7 Q` S `:sGQ%`$ R IGBMC5 S `:sGQ%`$5 F`:JHV E6 V`J:C RV]Q` V`s7 P`8 JV:J P1V``V SIFFROI T]1 :C'R;*J`:J -'.`I:JR'1`Q%--V:%5'6:`1-5'7`:JHV P`8 CCXIVJ JIMENE LVs HT]1 :%6 R% CH5 BQ`RV:%65 F`:JHV IJ V`J:C RV]Q` V`s7 P`8 J:IVC CHELL IGBMC5 S `:sGQ%`$5 F`:JHV T.V 1I]Q` :J .1J$ 1s JQ Q s Q] _%Vs 1QJ1J$8 C%`1Qs1 7 .:s 1 s Q1J `V:sQJ `Q` V61s 1J$8 ACGV` E1Js V1J R AH@JQ1CVR$VIVJ s I 11s.
    [Show full text]
  • Diagnostic Testing for Female Infertility
    Fact Sheet From ReproductiveFacts.org The Patient Education Website of the American Society for Reproductive Medicine Diagnostic Testing for Female Infertility An evaluation of a woman for infertility is appropriate for women over age 35 years; 2) have a family history of early menopause; 3) who have not become pregnant after having 12 months of regular, have a single ovary; 4) have a history of previous ovarian surgery, unprotected intercourse. Being evaluated earlier is appropriate chemotherapy, or pelvic radiation therapy; 5) have unexplained after six months for women who are older than age 35 or who have infertility; or 6) have shown poor response to gonadotropin ovarian one of the following in their medical history or physical examination: stimulation. • History of irregular menstrual cycles (over 35 days apart or no periods at all) Other Blood Tests: Thyroid-stimulating hormone (TSH) and • Known or suspected problems with the uterus (womb), tubes, prolactin levels are useful to identify thyroid disorders and or other problems in the abdominal cavity (like endometriosis hyperprolactinemia, which may cause problems with fertility, or adhesions) menstrual irregularities, and repeated miscarriages. In women • Known or suspected male infertility problems who are thought to have an increase in hirsutism (including hair on the face and/or down the middle of the chest or abdomen), Any evaluation for infertility should be done in a focused and cost- blood tests for dehydroepiandrosterone sulfate (DHEAS), 17-α effective way to find all relevant factors, and should include the hydroxyprogesterone, and total testosterone should be considered. male as well as female partners. The least invasive methods A blood progesterone level drawn in the second half of the menstrual that can detect the most common causes of infertility should be cycle can help document whether ovulation has occurred.
    [Show full text]
  • Infertility in the Military
    Updated May 26, 2021 Infertility in the Military In recent years, Congress has become increasingly 8,744 were diagnosed with infertility from 2013 to 2018. interested in the provision of infertility services and During this same time period, the annual incidence rate of expanded reproductive care for servicemembers. Federal infertility diagnoses decreased by 25.3% (from 85.1 per regulation (32 C.F.R. §199.4(g)) generally prohibits the 10,000 to 63.6 per 10,000 [see Figure 1]); while the Department of Defense (DOD) from paying for certain average annual prevalence of diagnosed female infertility infertility services for most servicemembers and other decreased by 18% (from 173.6 per 10,000 to 142.3 per beneficiaries eligible for the TRICARE program. Some 10,000 [see Figure 2]). Members of Congress argue that TRICARE coverage of Figure 1. Annual incidence rates of female infertility infertility services is an essential benefit to recruit and retain an all-volunteer force, while others express concern diagnoses, active component servicewomen of childbearing potential, 2013-2018 that expanded coverage would make the benefit too costly. This In Focus describes the prevalence of infertility among servicemembers, available treatment options, and considerations when addressing expanded TRICARE coverage of infertility services for servicemembers. Background The U.S. Centers for Disease Control and Prevention (CDC), defines infertility as “not being able to conceive after one year of regular, unprotected sexual intercourse.” Some health care providers, military and civilian, choose to evaluate and treat females over age 35 after 6 months of unprotected intercourse. Any condition affecting the ovaries, fallopian tubes and/or uterus can result in infertility among females.
    [Show full text]
  • Endometriosis-Related Infertility: Ovarian Endometrioma Per Se Is Not Associated with Presentation for Infertility
    Human Reproduction, Vol.31, No.8 pp. 1765–1775, 2016 Advanced Access publication on April 29, 2016 doi:10.1093/humrep/dew093 ORIGINAL ARTICLE Infertility Endometriosis-related infertility: ovarian endometrioma per se is not associated with presentation for infertility P. Santulli1,2,3, M.C. Lamau1, L. Marcellin1,3,V.Gayet1, P. Marzouk1, B. Borghese1,2, Marie-Christine Lafay Pillet1, and C. Chapron1,2,* 1Service de Chirurgie Gyne´cologie Obste´trique II et Me´decine de la Reproduction, Universite´ Paris Descartes, Sorbonne Paris Cite´, Faculte´ de Me´decine, Assistance Publique – Hoˆpitaux de Paris (AP-HP), Hoˆpital Universitaire Paris Centre (HUPC), Centre Hospitalier Universitaire (CHU) Cochin, Paris, France 2Equipe Ge´nomique, Epige´ne´tique et Physiopathologie de la Reproduction, De´partement De´veloppement, Reproduction, Cancer, Inserm U1016, Universite´ Paris Descartes, Sorbonne Paris Cite´, Faculte´ de Me´decine, AP-HP, HUPC, CHU Cochin, Paris,France 3Equipe Stress Oxydant, Prolife´ration Cellulaire et Inflammation, De´partement De´veloppement, Reproduction, Cancer, Inserm U1016, Universite´ Paris Descartes, Sorbonne Paris Cite´, Faculte´ de Me´decine, AP-HP, HUPC, CHU Cochin, Paris, France *Correspondence address. Service de Chirurgie Gyne´cologie Obste´trique II et Me´decine de la Reproduction, Baˆtiment Port Royal, CHU Cochin, 53 avenue de l’Observatoire, 75679 Paris 14, France. Tel: +33-1-58-41-36-69; Fax: +33-1-58-41-36-68; E-mail: [email protected] Submitted on November 2, 2015; resubmitted on February 24, 2016; accepted on March 23, 2016 study question: Is there an association between the endometriosis phenotype and presentation with infertility? summaryanswer: In a population of operated patients with histologically proven endometriosis, ovarian endometrioma (OMA) per se is not associated with an increased risk of presentation with infertility, while previous surgery for endometriosis was identified as a risk factor for infertility.
    [Show full text]
  • Effects of Endometriosis on Sleep Quality of Women: Does Life Style
    Youseflu et al. BMC Women's Health (2020) 20:168 https://doi.org/10.1186/s12905-020-01036-z RESEARCH ARTICLE Open Access Effects of endometriosis on sleep quality of women: does life style factor make a difference? Samaneh Youseflu1, Shahideh Jahanian Sadatmahalleh1* , Ghazall Roshanzadeh1, Azadeh Mottaghi2, Anoshirvan Kazemnejad3 and Ashraf Moini4,5,6 Abstract Background: This study aimed to compare the lifestyle factors and SQ between women with and without endometriosis. Also in this essay, the influence of food intake, socio-demographic and clinical characteristics on sleep quality of women with endometriosis was determined. Methods: Of the 156 infertile women approached for the study, 78 women had endometriosis and 78 were included in the control group. At first, each participant completed a checklist including questions about demographics, physical activity, reproductive and menstrual status. SQ was assessed by the Pittsburgh Sleep Quality Index (PSQI). Dietary data were collected using a validated 147-item semi-quantitative FFQ. Results: Irregular menstrual status, menorrhagia, dysmenorrhea, pelvic pain, history of abortion, family history of endometriosis were associated with endometriosis risk (P < 0.05). In women with physical activity more than 3 h per week, high consumption of the dairy product, and fruit endometriosis is less common (P < 0.05). The total PSQI score, and the scores for subjective sleep quality, sleep latency, sleep disturbance domains were significantly different between the two groups (P < 0.05). In women with endometriosis, poor SQ was associated with dysmenorrhea, pelvic pain, dyspareunia, physical activity, and low consumption of the dairy product, fruit, and nut (p < 0.05). Conclusion: In endometriosis women, SQ was lower than healthy individuals.
    [Show full text]
  • Cellular and Molecular Aspects of the Response of the Testis to Nutrition In
    Cellular and molecular aspects of the response of the testis to nutrition in sexually mature sheep Yongjuan Guan 21004548 This thesis is presented for the degree of Doctor of Philosophy of The University of Western Australia School of Animal Biology Institute of Agriculture March 2015 Declaration Declaration The work presented in this thesis is original work of the author, and none of the material in this thesis has been submitted either in full, or part, for a degree at this university or any other universities or institutions before. The experimental designs and manuscript preparation were carried out by myself after discussion with my supervisors Prof Graeme Martin, A/Prof Irek Malecki and Dr Penny Hawken. Yongjuan Guan March 2015 1 Contents Contents Summary ....................................................................................................................................... 4 Acknowledgements ....................................................................................................................... 8 Publications ................................................................................................................................. 10 Chapter 1: General Introduction ................................................................................................. 12 Chapter 2: Literature Review ...................................................................................................... 16 2.1 Male reproduction ............................................................................................................
    [Show full text]
  • Major Spliceosome Defects Cause Male Infertility and Are Associated with Nonobstructive Azoospermia in Humans
    Major spliceosome defects cause male infertility and are associated with nonobstructive azoospermia in humans Hao Wua,b,1, Liwei Sunc,d,1, Yang Wena,e,1, Yujuan Liua,b, Jun Yua,b, Feiyu Maoc,f, Ya Wanga,b, Chao Tongg, Xuejiang Guoa,b, Zhibin Hua,e, Jiahao Shaa,b, Mingxi Liua,b,2, and Laixin Xiac,2 aState Key Laboratory of Reproductive Medicine, Nanjing Medical University, Nanjing 210029, People’s Republic of China; bDepartment of Histology and Embryology, Nanjing Medical University, Nanjing 210029, People’s Republic of China; cKey Laboratory of Zebrafish Modeling and Drug Screening for Human Diseases of Guangdong Higher Education Institutes, Department of Developmental Biology, School of Basic Medical Sciences, Southern Medical University, Guangzhou 510515, People’s Republic of China; dState Key Laboratory of Biomembrane and Membrane Biotechnology, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, People’s Republic of China; eDepartment of Epidemiology and Biostatistics, School of Public Health, Nanjing Medical University, Nanjing 211166, People’s Republic of China; fState Key Laboratory of Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, People’s Republic of China; and gLife Sciences Institute and Innovation Center for Cell Biology, Zhejiang University, Hangzhou 310058, People’s Republic of China Edited by Margaret T. Fuller, Stanford University School of Medicine, Stanford, CA, and approved February 19, 2016 (received for review July 12, 2015) Processing of pre-mRNA into mRNA is an important regulatory Drosophila (9). Therefore, Drosophila provides a simple system mechanism in eukaryotes that is mediated by the spliceosome, a for investigating the complex genetic basis and related mo- huge and dynamic ribonucleoprotein complex.
    [Show full text]
  • Endometrial Immune Dysfunction in Recurrent Pregnancy Loss
    International Journal of Molecular Sciences Review Endometrial Immune Dysfunction in Recurrent Pregnancy Loss Carlo Ticconi 1,*, Adalgisa Pietropolli 1, Nicoletta Di Simone 2,3, Emilio Piccione 1 and Asgerally Fazleabas 4 1 Department of Surgical Sciences, Section of Gynecology and Obstetrics, University Tor Vergata, Via Montpellier, 1, 00133 Rome, Italy; [email protected] (A.P.); [email protected] (E.P.) 2 U.O.C. di Ostetricia e Patologia Ostetrica, Dipartimento di Scienze della Salute della Donna, del Bambino e di Sanità Pubblica, Fondazione Policlinico Universitario A.Gemelli IRCCS, Laego A. Gemelli, 8, 00168 Rome, Italy; [email protected] 3 Istituto di Clinica Ostetrica e Ginecologica, Università Cattolica del Sacro Cuore, Largo A. Gemelli 8, 00168 Rome, Italy 4 Department of Obstetrics, Gynecology, and Reproductive Biology, College of Human Medicine, Michigan State University, Grand Rapids, MI 49503, USA; [email protected] * Correspondence: [email protected]; Tel.: +39-6-72596862 Received: 17 September 2019; Accepted: 24 October 2019; Published: 26 October 2019 Abstract: Recurrent pregnancy loss (RPL) represents an unresolved problem for contemporary gynecology and obstetrics. In fact, it is not only a relevant complication of pregnancy, but is also a significant reproductive disorder affecting around 5% of couples desiring a child. The current knowledge on RPL is largely incomplete, since nearly 50% of RPL cases are still classified as unexplained. Emerging evidence indicates that the endometrium is a key tissue involved in the correct immunologic dialogue between the mother and the conceptus, which is a condition essential for the proper establishment and maintenance of a successful pregnancy.
    [Show full text]
  • Genetic Evaluation of Patients with Non-Syndromic Male Infertility
    Journal of Assisted Reproduction and Genetics https://doi.org/10.1007/s10815-018-1301-7 REVIEW Genetic evaluation of patients with non-syndromic male infertility Ozlem Okutman1,2 & Maroua Ben Rhouma1 & Moncef Benkhalifa3 & Jean Muller4,5 & Stéphane Viville1,2 Received: 24 July 2018 /Accepted: 28 August 2018 # Springer Science+Business Media, LLC, part of Springer Nature 2018 Abstract Purpose This review provides an update on the genetics of male infertility with emphasis on the current state of research, the genetic disorders that can lead to non-syndromic male infertility, and the genetic tests available for patients. Methods A comprehensive review of the scientific literature referenced in PubMed was conducted using keywords related to male infertility and genetics. The search included articles with English abstracts appearing online after 2000. Results Mutations in 31 distinct genes have been identified as a cause of non-syndromic human male infertility, and the number is increasing constantly. Screening gene panels by high-throughput sequencing can be offered to patients in order to identify genes involved in various forms of human non-syndromic infertility. We propose a workflow for genetic tests which takes into account semen alterations. Conclusions The identification and characterization of the genetic basis of male infertility have broad implications not only for understanding the cause of infertility but also in determining the prognosis, selection of treatment options, and management of couples. Genetic diagnosis is essential for the success of ART techniques and for preserving future fertility as well as the prognosis for testicular sperm extraction (TESE) and adopted therapeutics. Keywords Male infertility . Non-syndromic .
    [Show full text]